Mostafa Belghasem, M.D., Ph.D
Associate Professor
Positions
- Associate Professor
-
School of Medicine - Temple
Baylor College of Medicine
Temple, US
Education
- PhD from Boston University
- Boston
- Pathology
Honors & Awards
- Raise the Line Faculty Award: MD/ DO Category
- Osmosis by Elsevier (12/2022)
- Innovations in Kidney Education Contest Winner
- American Society of Nephrology (ASN) (10/2021)
- The Excellence Award for Outstanding Contributions
- Department of Pathology, Boston University (07/2016)
- Ethics in Action Champion Award
- Kaiser Permanente (10/2022)
- Kidney STARS Award
- American Society of Nephrology (11/2014)
- Teaching as Research Fellowship Award
- Boston University (09/2014)
- Positive Learning Environment Commendations Recipient
- Kaiser Permanente School of Medicine (06/2021 - 06/2022)
- Golden Apple Teaching Award, Outstanding Basic Scientist
- Baylor College of Medicine (07/2024)
- Professional Educator Appreciation and Recognition (PEAR) Award
- Baylor College of Medicine (12/2023)
Professional Statement
Dr. Mostafa Belghasem is a physician-scientist and a passionate biomedical educator. At BCM, he will serve as the Pathology Co-Thread Director.
Dr. Belghasem has demonstrated a lifelong commitment to teaching and mentoring medical students, graduate medical students, residents, and research fellows. He has implemented innovative instructional design strategies and learning methodologies that foster active learning, clinical reasoning and teamwork. Dr. Belghasem has also supported faculty in implementing new instructional methods to ensure continuous improvement and excellence in educational design. In line with these attributes, he is recognized nationally and has won prestigious awards. Most recently, he has won the 2022 “Raise the Line Faculty Award” for the MD/ DO Category. This award is offered by Osmosis from Elsevier to recognize the work of exceptional health educators who are helping to “raise the line” by improving the medical education standards. Dr. Belghasem is highly committed to research and is presently engaged in many fruitful national-level collaborations that allow him to continue to make valuable contributions to science.
Dr. Belghasem has demonstrated a lifelong commitment to teaching and mentoring medical students, graduate medical students, residents, and research fellows. He has implemented innovative instructional design strategies and learning methodologies that foster active learning, clinical reasoning and teamwork. Dr. Belghasem has also supported faculty in implementing new instructional methods to ensure continuous improvement and excellence in educational design. In line with these attributes, he is recognized nationally and has won prestigious awards. Most recently, he has won the 2022 “Raise the Line Faculty Award” for the MD/ DO Category. This award is offered by Osmosis from Elsevier to recognize the work of exceptional health educators who are helping to “raise the line” by improving the medical education standards. Dr. Belghasem is highly committed to research and is presently engaged in many fruitful national-level collaborations that allow him to continue to make valuable contributions to science.
Selected Publications
-
Moshe Shashar, Mostafa Belghasem, Vipul C. Chitalia.. " Targeting STUB1-tissue factor axis normalizes hyperthrombotic uremic phenotype without increasing bleeding risk " Sci Transl Med.. 2017 ;
Pubmed PMID: 29167396. -
Belghasem M, Roth D, Richards S, Napolene MA, Walker J, Yin W, Arinze N, Lyle C, Spencer C, Francis JM, Thompson C, Andry C, Whelan SA, Lee N, Ravid K, Chitalia VC.. " Metabolites in a mouse cancer model enhance venous thrombogenicity through the aryl hydrocarbon receptor-tissue factor axis. " Blood. 2019 ;
Pubmed PMID: 31877217. -
Belghasem ME, A'amar O, Roth D, Walker J, Arinze N, Richards SM, Francis JM, Salant DJ, Chitalia VC, Bigio IJ.. " Towards minimally-invasive, quantitative assessment of chronic kidney disease using optical spectroscopy " Sci Rep.. 2019 ;
Pubmed PMID: 31073168. -
Lyle CL, Belghasem M, Chitalia VC.. " c-Cbl: An Important Regulator and a Target in Angiogenesis and Tumorigenesis. " Cells.. 2019 ;
Pubmed PMID: 31126146.
Log In to edit your profile